Cardiovascular
Inhibikase sees “opportunity” in cardiopulmonary disease for IkT-001Pro
Inhibikase Therapeutics is eying pulmonary arterial hypertension (PAH) as a potential indication for its imatinib alternative IkT-001Pro. In an 18…
Vivasure implants first venous patient in PerQseal device trial
Vivasure Medical has treated the first venous patient in a clinical trial investigating its PerQseal Elite vascular closure system for…
Weill Cornell-led trial of etripamil shows promise for PSVT
Weill Cornell Medicine in the US has led a clinical trial of the etripamil nasal spray to safely treat recurrent…
ACC24: V-Wave interatrial shunt misses primary endpoint
US-based medical device company V-Wave released primary data from the RELIEVE-HF pivotal trial of its Ventura interatrial shunt. The randomised…
Boehringer and Lilly report data from heart failure treatment trial
Boehringer Ingelheim and Eli Lilly have reported data from the Phase III EMPACT-MI clinical trial of Jardiance (empagliflozin) on the…
Kardium’s pulsed field ablation clinical trial enters final stages
Kardium has completed enrolment in a study evaluating its pulsed-field ablation (PFA) device for the treatment of atrial fibrillation. According…
Concept wins another IDE from FDA for MagicTouch range
The US Food and Drug Administration (FDA) has granted Concept Medical an investigational device exemption (IDE) for its MagicTouch arteriovenous…
Auxilius Pharma to launch Phase Ib anti-anginal trial after IND application
Auxilius Pharma will be submitting an investigative new drug (IND) application for AUX-001 with plans to initiate a Phase Ib…
Sequana’s DSR therapy shows promise in heart failure patients
Belgium-based Sequana Medical has released data from the Phase I/II MOJAVE study in the US, which is evaluating its direct…
AstraZeneca kick-starts Phase III COPD trial for Breztri
AstraZeneca has launched a Phase III THARROS trial to evaluate the efficacy of its triple-combination inhaled therapy Breztri (budesonide /…
